Forbion Growth Management B.V. insider trades
Forbion Growth Management B.V. has filed 3 Form 4s with the SEC that we hold, for FRBNU (Director, 10% owner), NewAmsterdam Pharma Co N.V. (NAMS) (10% owner) and enGene Therapeutics Inc. (ENGN) (10% owner). Across all of them we count 1 purchase worth $5.0M and 5 sales worth $11.7M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 259,739 shares of NewAmsterdam Pharma Co N.V. worth $6.6M, dated 2024-12-10. The first filing on our record is dated 2023-10-31 and the latest 2024-12-12.
FRBNU
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
NewAmsterdam Pharma Co N.V. (NAMS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-10 | S, sale reported on Form 4 | 48,511 | $1.3M | 2024-12-12 |
| 2024-12-10 | S, sale reported on Form 4 | 259,739 | $6.6M | 2024-12-12 |
| 2024-12-11 | S, sale reported on Form 4 | 130,561 | $3.3M | 2024-12-12 |
| 2024-12-11 | S, sale reported on Form 4 | 18,583 | $490.8K | 2024-12-12 |
| 2024-12-11 | S, sale reported on Form 4 | 4,894 | $132.7K | 2024-12-12 |
enGene Therapeutics Inc. (ENGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-10-30 | P, purchase reported on Form 4 | 561,797 | $5.0M | 2024-11-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1918318) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms